New Drug Application of Zydus’ Desidustat tablets by China Medical System Holdings accepted in China Read more
Zydus gets USFDA nod for Dexamethasone Tablets USP, 0.5 mg, 0.75 mg, 1.5 mg, 4 mg and 6 mg and Dexamethasone Tablets USP, 2 mg Read more
Zydus, Daewoong sign licensing pact to develop, market Leuprolide long-acting injectable in US Read more